Schedule 13G ownership disclosure
Immunome Inc
Common Stock · CUSIP: 45257U108
Event date: 2025-06-30
- Filing-level shares
- 4,524,952
- Percent of class
- 5.20%
- The Vanguard Group
Shares: 4,524,952 · Class: 5.20%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000844
- Form type
- SCHEDULE 13G
- Filer
- Immunome Inc.
- CIK
- CIK 1472012
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership